Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Tasigna Lawsuit Moves Forward, After Interlocutory Appeal of Preemption Ruling Denied A federal judge determined the lawsuit was not barred due to preemption laws, after plaintiff brought evidence suggesting Novartis had new information which could have led to updated label warnings. January 10, 2022 Irvin Jackson Add Your Comments After a federal judge denied a motion filed by Novartis to dismiss a lawsuit over Tasigna heart risks on pre-emption grounds, the Court rejected the drug maker’s request to allow an immediate appeal of the issue, allowing the case to move forward in the trial court. Tasigna (nilotinib) was approved by the FDA in 2007, and is part of a class of medications known as kinase inhibitors, which are prescribed for treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) among recently diagnosed adults. While the drug carries a “black box” warning about the risk of QT prolongation, which is a heart rhythm problem that can result in sudden death, Novartis now faces a growing number of Tasigna lawsuits that allege patients and doctors were not adequately warned that the medication may cause blood flow problems, which may lead to atherosclerosis, a stroke, heart attack, amputations or death. Learn More About Tasigna Lawsuits Side effects of Tasigna may increase risk of heart attack, stroke, amputation and wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Tasigna Lawsuits Side effects of Tasigna may increase risk of heart attack, stroke, amputation and wrongful death. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In an early complaint (PDF) filed in the U.S. District Court for the District of Connecticut in March 2020, Novartis filed a motion to dismiss, arguing that the claim filed by Sheila Colella should be pre-empted by federal law, since the FDA approved the medication and warning label. While the motion only applied to the one case, the filing was closely watched as a potential signal for how other judges may rule on similar motions. In October, U.S. District Judge Roy B. Dalton, Jr., who is overseeing centralized Tasigna lawsuits filed in federal courts nationwide for pretrial proceedings in the U.S. District Court for the Middle District of Florida, denied the motion and pointed out in a pretrial order (PDF) that Colella’s lawsuit “specifically alleges—and the Court accepts as true— that Defendant had newly acquired information not only permitting it, but in fact requiring it, to change the label via the CBE regulation without prior FDA approval.” Following the ruling, Novartis sought an immediate appeal of that decision, known as an interlocutory appeal, which would allow the appellate court to consider the issue before a final judgments is issued in the case. However, in a court order (PDF) issued on January 4, Judge Dalton rejected the request, finding that Novartis failed to meet the burden necessary to warrant a “rare exception” to the policy against piecemeal appeals. As part of the coordinated pretrial proceedings, it is expected that a series of early trial dates will be scheduled, which may help the parties gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation, and potentially facilitate Tasigna settlements without the need for each individual case to go to trial. Tags: Amputation, Novartis, Peripheral Artery Disease, Tasigna More Tasigna Lawsuit Stories Tasigna Atherosclerosis Risks Concealed from Doctors, Patients in U.S.: Lawsuit June 19, 2023 Tasigna Side Effects Led To Partial Leg Amputation, Lawsuit Claims November 1, 2021 Wrongful Death Lawsuit Filed Over Tasigna Heart Injury Risk September 28, 2021 1 Comments Regina February 25, 2022 Took tasigna in 2011 effected my heart rate and it is still not normal in2022 Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (Posted: today) A federal judge has appointed a special master to help parties involved in hair relaxer lawsuits potentially negotiate a settlement to resolve the litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025) Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (Posted: today) A federal judge has added three additional ulcerative colitis claims to a pool of AFFF lawsuits being prepared for early test trials. MORE ABOUT: AFFF LAWSUITFirefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)Apple Watch PFAS Lawsuit Alleges Toxic Chemicals in Wrist Bands Could Increase Cancer Risks (03/14/2025) Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects (Posted: yesterday) A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye. MORE ABOUT: OZEMPIC LAWSUITOzempic-Related Emergency Room Visits Are Often Caused by Gastrointestinal Issues: Study (04/23/2025)Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (04/18/2025)Ozempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)
Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (Posted: today) A federal judge has appointed a special master to help parties involved in hair relaxer lawsuits potentially negotiate a settlement to resolve the litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)
Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (Posted: today) A federal judge has added three additional ulcerative colitis claims to a pool of AFFF lawsuits being prepared for early test trials. MORE ABOUT: AFFF LAWSUITFirefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)Apple Watch PFAS Lawsuit Alleges Toxic Chemicals in Wrist Bands Could Increase Cancer Risks (03/14/2025)
Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects (Posted: yesterday) A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye. MORE ABOUT: OZEMPIC LAWSUITOzempic-Related Emergency Room Visits Are Often Caused by Gastrointestinal Issues: Study (04/23/2025)Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (04/18/2025)Ozempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)